Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts

被引:57
作者
Boukouvala, S [1 ]
Sim, E [1 ]
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
关键词
D O I
10.1111/j.1742-7843.2005.pto_02.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Arylamine N-acetyltransferases are polymorphic drug-metabolising enzymes. The human isoforms, NAT1 and NAT2, are encoded by two genes with intronless coding regions. Human NAT1 protein is found in many tissues, unlike NAT2 which is present predominantly in the intestine and liver. We describe the exon-intron structure of the human NAT genes by analysing data from genomic databases. Comparison of expressed sequence tags, matching NAT gene sequences, with the sequence of human chromosome 8 implied the presence of 8 non-coding exons located 51.5, 51.4, 12.3, 11.9, 10.8, 9.6, 5.2 and 2.6 kb upstream of the single coding exon of the NAT1 gene. A number of expressed sequence tags also indicated transcription initiation from the upstream region adjacent to the NAT1 coding exon, consistent with earlier studies. The NAT2 gene consists of one previously. described non-coding and one coding exon, located 8.6 kb apart. These findings were also confirmed by RT PCR, using cDNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Alternatively spliced NAT1 transcripts were found in all tissues. Transcription of the NAT2 gene was also detected in these tissues and was demonstrated to start either from the non-coding exon or from immediately upstream of the coding exon. Comparison of the RT PCR products provided an initial estimate of the relative amounts of the different NAT transcripts expressed in each tissue. Finally, both expressed sequence tag analysis and RTPCR demonstrated the presence of two differentially utilised polyadenylation signals for NAT1 and NAT2, located about 0.2 and 0.3 kb downstream of the coding region of each gene.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 33 条
[1]  
Adam PJ, 2003, MOL CANCER RES, V1, P826
[2]  
BADAWI AF, 1995, CANCER RES, V55, P5230
[3]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[4]   NUCLEOTIDE-SEQUENCE OF A FULL-LENGTH CDNA FOR ARYLAMINE N-ACETYLTRANSFERASE FROM RABBIT LIVER [J].
BLUM, M ;
GRANT, DM ;
DEMIERRE, A ;
MEYER, UA .
NUCLEIC ACIDS RESEARCH, 1989, 17 (09) :3589-3589
[5]   Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice [J].
Boukouvala, S ;
Price, N ;
Plant, KE ;
Sim, E .
BIOCHEMICAL JOURNAL, 2003, 375 :593-602
[6]   Pharmacogenetics of the arylamine N-acetyltransferases [J].
Butcher N.J. ;
Boukouvala S. ;
Sim E. ;
Minchin R.F. .
The Pharmacogenomics Journal, 2002, 2 (1) :30-42
[7]   Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1) [J].
Butcher, NJ ;
Arulpragasam, A ;
Pope, C ;
Minchin, RF .
BIOCHEMICAL JOURNAL, 2003, 376 :441-448
[8]   Directing alternative splicing: Cast and scenarios [J].
Chabot, B .
TRENDS IN GENETICS, 1996, 12 (11) :472-478
[9]   STRUCTURE AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF GENES FOR HUMAN LIVER ARYLAMINE N-ACETYLTRANSFERASES [J].
EBISAWA, T ;
DEGUCHI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (03) :1252-1257
[10]   COMPLEMENTARY DNAS FOR 2 ARYLAMINE N-ACETYLTRANSFERASES WITH IDENTICAL 5' NONCODING REGIONS FROM RAT PINEAL-GLAND [J].
EBISAWA, T ;
SASAKI, Y ;
DEGUCHI, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 228 (01) :129-137